4.7 Review

Probiotics and the gut microbiota in intestinal health and disease

期刊

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrgastro.2010.117

关键词

-

资金

  1. National Institutes of Health [R01 HD012437, R01 DK070260, P01 DK033506, P30 DK040561]
  2. Canadian Institutes of Health Research
  3. Crohn's and Colitis Foundation of Canada
  4. CIHR/CCFC/Canadian Association of Gastroenterology
  5. Canada Research Chair in Gastrointestinal Disease
  6. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK070260, P30DK040561] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The use of probiotics is increasing in popularity for both the prevention and treatment of a variety of diseases. While a growing number of well-conducted, prospective, randomized, controlled, clinical trials are emerging and investigations of underlying mechanisms of action are being undertaken, questions remain with respect to the specific immune and physiological effects of probiotics in health and disease. This Review considers recent advances in clinical trials of probiotics for intestinal disorders in both adult and pediatric populations. An overview of recent in vitro and in vivo research related to potential mechanisms of action of various probiotic formulations is also considered.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据